Migraine Headache Prevention Headlines
Botox approved for migraines
The use of botox is approved as a preventive treatment for chronic migraine by UK drug regulators.
Read more...
BOTOX(R) Receives First Authorisation In UK As Preventative Treatment In Chronic Migraine
Allergan has today announced that BOTOX® (botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine)1. This is the first licence worldwide of BOTOX® for this indication, and is also the first prophylactic (preventative) treatment to ...
Read more...
Britain approves Allergan's Botox drug for migraine
Britain has become the first country to approve Allergan Inc's anti-wrinkle injection Botox as a treatment for migraine, opening up a new market for the product.
Read more...
Botox, treatment for migraine
LONDON - BRITAIN became the first country in the world to approve Allergan Inc's anti-wrinkle injection Botox as a treatment for migraine on Friday, opening up a new market for the product. US drugmaker Allergan said Botox had been licensed by British regulators for the prevention of headaches in adults with chronic migraine.
Read more...
Allergan receives UK MHRA authorisation of BOTOX for prophylaxis of headache in chronic migraine
Allergan is pleased to announce that BOTOX® (botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine). This is the first licence worldwide of BOTOX® for this indication, and is also the first prophylactic (preventative) treatment to ...
Read more...
Press Release
Allergan Inc. Posted on:09 Jul 10 Allergan is pleased to announce that BOTOX®(botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine)1. This is the first licence worldwide of BOTOX® for this indication, and is also the first ...
Read more...
|
